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Human cytomegalovirus (CMV) is the most common 
cause of congenital and perinatal infections throughout 
the world. The prevalence of congenital CMV infection 
varies widely between different populations (0.2-3.0%). 
Less than 5% of infants with congenital CMV infection 
have typical cytomegalic inclusion disease, another 5% 
have atypical involvement, and the remainder (90%) 
are asymptomatic at the time of delivery.’ Even when 
asymptomatic at birth, 5--17% of infants with these 
asymptomatic congenital CMV infections will develop 
progressive sensorineural hearing loss or other neuro- 
developmental difficulties within the first 4 years of life. 
We have studied the incidence of congenital CMV 
infection in Japan. Of 7995 Japanese neonates, 31(0.39%) 
were identified as having congenital CMV infections 
on the basis of viruria at birth. Three of 31 infants had 
clinically severe disease resulting in death during the 
neonatal period. Prospective studies of children born 
with asymptomatic congenital CMV infection have also 
revealed a wide but significant spectrum of neurologic 
complications. A decrease in the prevalence of serum 
antibodies against CMV has been seen in recent years 
as a consequence of improvements in the social and 
economic conditions in Japan in the last 20 years.* 
From January to December 1988, serum samples 
were collected from 173 Japanese pregnant women who 
visited a hospital in Sapporo, Japan, at 32-36 weeks 
of gestation. Serum samples were also obtained from 
345 pregnant women who visited the same hospital at 
the same stage of gestation during January 1999 to June 
2000. Informed consent was obtained from those parti- 
cipating. CMV PCS (pipetted control system) Medac 
IgG and IgM test kits, kindly supplied by Medac Diag- 
nostika, Hamburg, Germany, were used to detect serum 
IgG and IgM antibodies against CMV. All serum samples, 
from both 1988 and 1999-2000, were tested at the same 
time. Testing and interpretation of the results were 
performed according to the manufacturer’s instructions. 
Two hundred and thirty-five of 345 (68.1%) Japanese 
pregnant women at 32-36 weeks of gestation had IgG 
and seven (2.0%) had IgM antibodies to CMV in the 
years 1999-2000 in Sapporo, Japan, by enzyme immuno- 
assay. One hundred and forty-seven of 173 (85.0%) sera 
had IgG and one (0.6%) had IgM antibodies in 1988. 
One hundred and sixty-one of 354 sera (46.7%) from the 
years 1999-2000 showed optical density (OD) titers of 
IgG antibody of more than 1.000. On the other hand, 
only three (1.7%) of 173 sera from 1988 showed OD 
Table 1. Prevalence of serum antibodiesto CMV in pregnant women in Sapporo,Japan 
OD value 
1988 1999-2000 
IgG W 196 ISM 
0.000-0.200 26 (15.0%) 172 (99.4%) 110 (31.9%) 338 (98.0%) 
0.201-0.400 36 (20.8%) 1 (0.6%) 13 (3.8%) 2 (0.6%) 
0.401-0.600 64 (37.0%) 0 21 (6.1%) 3 (0.9%) 
0.601-0.800 35 (20.2%) 0 11 (3.2%) 0 
0.801-1.000 9 (5.2%) 0 29 (8.4%) 1 (0.3%) 
> 1 .ooo 3 (1.7%) 0 161 (46.7%) 1 (0.3%) 
Total 1471173 II173 2351345 71345 
Seropositive (85.0%) (0.6%) (68.1%) (2.0%) 
Cutoff value: 0.200 OD. 
titers of IgG antibody of more than 1.000 (Table 1). 
Mean OD titers of serum IgG antibody during 1999- 
Department of Pediatrics, Sapporo Medical University School of Medi- 2000 were significantly higher than those from 1988 
tine, Sapporo, Japan. (Welch’s t-test, PcO.05). 
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presence of high titers of serum IgG antibody during 
pregnancy are indicative of primary infection, but may 
Corresponding Editorial Of&e: New York be insufficient as a predictor for the risk of congenital 
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infection.3 The presence of serum anti-CMV IgM anti- 
body is also diagnostic evidence of primary or acute 
CMV infection, and may be seen with reactivation, 
along with IgG. 
Transmission of CMV by natural routes is im- 
portant with respect to preventing CMV transmission to 
seronegative pregnant women. CMV is isolated more 
frequently from cervical secretions and semen than from 
urine and other clinical specimens. Viral titers in semen 
were reported to be 100 000 times greater than those in 
urine. Evidence for sexual transmission of CMV was 
provided by determining the prevalence of serum anti- 
bodies to CMV and viral shedding in male sex partners 
of women with and without CMV infection.4 However, 
it is also necessary to take into account other potential 
sources of CMV infection, including exposure to young 
children who are excreting CMV. 
In certain countries, parental interest groups have 
called for screening programs for the general obstetric 
population in an attempt to reduce the rate of fetal 
damage with congenital CMV infection. The population 
of seropositive women of childbearing age in populations 
of low socio-economic status is about 85%, and that in 
populations of high socioeconomic status is about 55%. 
According to a previous report,5 more than 90% of 
the population in Japan was seropositive by 20 years of 
age. Primary CMV infection during pregnancy occurred 
in approximately 1% of susceptible women. Although 
social and economic conditions have improved drama- 
tically, it was also reported that the prevalence of CMV 
had been stable during 1976-90.5 Since annual live births 
in Japan used to be approximately 1.22 million, 4000- 
5000 infants with congenital CMV infection were pre- 
sumed to be born each year. From the results of the 
present study, cases of congenital CMV infection in 
Japan are considered to be increasing. 
Understanding the epidemiology of CMV is a key 
element in the development of strategies for the 
prevention of congenital infection. The prevalence of 
serum antibodies to CMV was decreasing and primary 
CMV infection during pregnancy was speculated to be 
increasing in Sapporo, Japan during 1988-2000. Entirely 
new approaches to prevention and treatment of con- 
genital CMV infection are necessary, including antiviral 
interventions and the development of a vaccine strategy. 
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